Chris Inquires About NHS Research Into Mast Cell Activation Syndrome
To ask the Secretary of State for Health and Social Care, whether the NHS has commissioned research into the potential impact of (a) Covid-19 and (b) Covid-19 vaccines on the (i) diagnosis and (ii) treatment of Mast Cell Activation Syndrome.
The Department commissions research through the National Institute for Health and Care Research (NIHR). Vaccines must be tested in a wide range of studies, including clinical trials to establish their efficacy and safety, and have a product licence, known as a “marketing authorisation” before they can be made available for widespread use in humans. Since the start of the COVID-19 pandemic, the NIHR has allocated over £110 million in funding for COVID-19 vaccine research that has included consideration of vaccine safety and robust monitoring of adverse reactions to COVID-19 vaccines.
The NIHR welcomes funding applications for research into any aspect of human health, including vaccine side effects.
- ENDS - #193836